ATS 2024 Final Program

Click on the session title to view the speakers

302

TUESDAY • MAY 21

310 Asthma Exacerbation Rates as a Function of Biomarker Levels 4 Weeks After Initiation of Tezepelumab Treatment: An Analysis of the NAVIGATOR Study 311 Biologics Use and Switch Patterns in the French Severe Asthma Cohort 312 Dupilumab Efficacy by Baseline Disease Severity Among Children With Uncontrolled Moderate-to-Severe Asthma: Post-hoc Results From the Randomized, Placebo-controlled VOYAGE Trial 313 Puerto Rican Infant Metagenomic and Epidemiologic Study of Respiratory Outcomes (PRIMERO): Design and Baseline Characteristics for Puerto Rico’s Inaugural Asthma Birth Cohort Study 314 Effect of Benralizumab Versus Mepolizumab on Reduction in Oral Glucocorticoid Use in Patients With Eosinophilic Granulomatosis With Polyangiitis: Phase 3 MANDARA Study 315 Uncovering Acute Exacerbations Via Reliever Use Patterns Using Digihaler Inhaler Data

704 COVID-19 Crisis Communication in a Linguistically Diverse Population: Evaluating Differences in Sources of Information and Perception of Risks Based on Language Preference 705 Barriers to Equitable Follow-up Care After COVID Hospitalization for Patients of Low Socioeconomic Status: A Qualitative Study of Ten U.S. Health Systems 706 Evaluating a Population-based Environmental Justice Index as a Tool for Predicting Individual Disparities and Care Quality Among People With Asthma 707 Disparities in Status Asthmaticus Death: A Cross-sectional Analysis 1999 - 2020 708 Clinical Trial Participation in Cystic Fibrosis Assessed by Race and Ethnicity 709 Neighborhood Level Socioeconomic Disadvantage and Adherence to Guidelines for Surveillance of Patients With Incidentally Detected Pulmonary Nodules Environmentally Burdened Communities Through Enhanced Risk Communication: A Pilot Randomized Trial 711 Understanding the Beliefs of Lung Cancer Screening Among Latinos: A Qualitative Study 712 Exploring Disparate Access to Care in Sarcoidosis Patients in Detroit, Michigan 713 Association Between Pre-transplant Psychosocial Risk Level and Post-transplant Outcomes in Lung Transplant Patients 714 Differences in Patient Characteristics and Clinical Outcomes at the Extremes of Physical Activity in Pulmonary Arterial Hypertension (PAH): A Pulmonary Hypertension Association Registry (PHAR) Study 715 Trends and Racial Disparities in Pulmonary Embolism Admissions From 2017 to 2023 716 Discrimination and Mistrust Among Patients With Serious Illness and Intersecting Identities 717 Comparison of Clinical Outcomes and Racial 710 Promoting Lung Cancer Screening in

BEHAVIORAL • CLINICAL POSTER DISCUSSION SESSION

C103 DISPARITIES AND SOCIAL

DETERMINANTS OF HEALTH IN PULMONARY, CRITICAL CARE, AND SLEEP MEDICINE

2:15 p.m. - 4:15 p.m.

San Diego Convention Center Room 30C-E (Upper Level)

Poster Viewing

2:15-3:00

Discussion 3:00-4:15 701 Objective Assessment of Sleep Apnea Prevalence in People Experiencing Homelessness 702 Investigating Speech-based Features in Differentiating Obstructive Sleep Apnea in People Experiencing Homelessness 703 Using an Expanded Diagnostic Criteria Mitigates Gender Disparities in Diagnosis of Sleep Disordered Breathing

Disparities Between Dedicated Versus Consultative Inpatient Pulmonary Care: A Retrospective Cohort Study

ATS 2024 Conference Program • San Diego, CA